1. Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels;Mohan;EBioMedicine,2020
2. Absence of developmental and reproductive toxicity in animals exposed to dolutegravir;Stanislaus;Birth Defects Res,2020
3. Using whole embryo culture to address risk to patients taking dolutegravir;Posobiec,2019
4. Current status of teratology;Wilson,1977
5. “The environment and disease: association or causation?.”;Hill;Journal of the Royal Society of Medicine,2015